Illumina Jan 26, 2026 Canaccord Genuity raises Illumina stock price target to $150 on solid results - Investing.com
BioPharma Dive Jan 26, 2026 From detection to prevention: How sponsored testing can transform patient outcomes
BioPharma Dive Jan 26, 2026 The crucial role of raw material selection for success in cell therapy manufacturing
Lonza News Jan 26, 2026 Lonza Group AG (LONN.SW, SIX): CHF550.20 intraday ahead of 28 Jan earnings — what to watch - Meyka
Thermo Fisher Jan 26, 2026 AEGON ASSET MANAGEMENT UK Plc Purchases 13,857 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
FierceBiotech Jan 26, 2026 'Things are looking up': British biotechs consider going public after yearslong IPO drought
Catalent Jan 26, 2026 Catalent moves to wind down operations at EU cell therapy manufacturing hub - Fierce Pharma
Mindray Jan 26, 2026 Egypt, China’s Mindray discuss localising medical device manufacturing, smart hospitals - Dailynewsegypt
Agilent Jan 26, 2026 Agilent Technologies, Inc. (A) Stock Analysis: A Compelling 25.63% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
eLife Jan 26, 2026 Axonal distribution of mitochondria maintains neuronal autophagy during aging via eIF2β
eLife Jan 26, 2026 Phenylhydrazone-based endoplasmic reticulum proteostasis regulator compounds with enhanced biological activity
10x Genomics Blog Jan 25, 2026 A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st
10x Genomics Blog Jan 25, 2026 A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st
Thermo Fisher Jan 25, 2026 Whittier Trust Co. Purchases 26,584 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Illumina Jan 25, 2026 Wealth Enhancement Advisory Services LLC Buys 9,997 Shares of Illumina, Inc. $ILMN - MarketBeat